Selinexor

Overview

Selinexor (KPT-330) is an analog of KPT-185 ( HY-15611 ). Selinexor is an orally active, selective CRM1 inhibitor that inhibits tumor growth by inducing PANoptosis .

Application

Products | Products > Disease Areas > Respiratory Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Non-Small Cell Lung Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CRM1 | Products > Signaling Pathways > PANoptosis

Product Information

• Catalog No.: HY-17536
• CAS No.: 1393477-72-9
• Molecular Formula: C17H11F6N7O
• Molecular Weight: 443.31
• Purity: 99.83%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.64 mM); Clear solution
• Availability: In-stock

Source

Original product source